NewsBite

GI Dynamics

June 2016

Stockmarket rock stars whose funds stand out from the crowd

Five fund managers who are star performers and how they got there.

  • Updated
  • James Frost

January 2016

Biotech companies have the same touchy reputation as speculative mining stocks.

Biotech stocks to get the heart racing … or slowing

Notoriously volatile and tricky to pick, biotechnology stocks gave nimble investors plenty of opportunity to outperform blue chips in 2015 and are set to provide some wild rides in 2016 too.

  • Updated
  • Jessica Sier

December 2014

The biggest biotechnology blunders of 2014

Biotechnology investors understand that their appetite for speculation brings both risk and reward, but it is likely that even the bravest stockpickers will be happy to leave 2014 behind.

  • Updated
  • Jessica Gardner

October 2014

GI Dynamics falls 50pc on product suspension

GI Dynamics investors aren’t waiting to see whether it can survive a suspension in sales of its main product to treat type 2 diabetes as the medical device maker’s shares fell 50 per cent.

  • Updated
  • Jessica Gardner

GI Dynamics falls 50pc on product suspension

GI Dynamics investors aren’t waiting to see whether it can survive a suspension in sales of its main product to treat type 2 diabetes as the medical device maker’s shares fell 50 per cent.

  • Updated
  • Jessica Gardner
Advertisement

August 2014

GI Dynamics (GID)

CIMB has an “add” recommendation on GI Dynamics and a $1.04 target price.

  • Updated
  • Will Willitts

July 2013

GI Dynamics placement upsized to $57.5 million

GI Dynamics’ placement of CHESS Depository Interests (CDIs) has been upscaled to $57.5 million from $35 million due to strong demand from local and domestic fund managers, sources told Street Talk Online on Wednesday.

  • Updated
  • Sarah Thompson | Anthony Macdonald | Gretchen Friemann

2013 a tough year for small caps

The past 12 months have been a miserable affair for many small caps, with the index now trading at its lowest point since April 2009.

  • Updated
  • Sally Rose

January 2013

San Fran pharma conference breeds deals

The JP Morgan Healthcare Conference in San Francisco currently underway is the biggest speed-dating event on the biotech calendar each year.

  • Sarah Thompson and Anthony Macdonald

March 2012

Bell Potter busy with dynamic trades

Bell Potter is understood to have handled trading in 25 million GI Dynamics securities on Wednesday, worth 8.5 per cent of the company.

  • Updated
  • ANTHONY MACDONALD | STEPHEN SHORE

ResMed competitor likely to list

ResMed may have a new competitor on the Australian Securities Exchange, with US-based Ventus Medical understood to be exploring a listing in Australia.

  • Updated
  • ANTHONY MACDONALD

January 2012

Healthy deals in San Francisco

It was at a chance meeting between some health industry heavy hitters in San Francisco this time last year that GI Dynamics decided to list in Australia, and the deal makers are back in the States this week.

  • Stephen Shore and anthony macdonald

December 2011

Float review: no survivors

Successful sharemarket floats were few and far between in the wreckage that was 2011. So what does that mean for 2012?

  • Updated
  • Tony Featherstone

Original URL: https://www.afr.com/company/gid-nj